Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
NOVT 
Novanta Inc (NOVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/04/2025: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $154
1 Year Target Price $154
| 1 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -42.11% | Avg. Invested days 46 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/04/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.11B USD | Price to earnings Ratio 78.27 | 1Y Target Price 154 |
Price to earnings Ratio 78.27 | 1Y Target Price 154 | ||
Volume (30-day avg) 4 | Beta 1.59 | 52 Weeks Range 98.27 - 173.16 | Updated Date 12/4/2025 |
52 Weeks Range 98.27 - 173.16 | Updated Date 12/4/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.46 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.5% | Operating Margin (TTM) 11.51% |
Management Effectiveness
Return on Assets (TTM) 5.18% | Return on Equity (TTM) 6.84% |
Valuation
Trailing PE 78.27 | Forward PE - | Enterprise Value 4503640056 | Price to Sales(TTM) 4.28 |
Enterprise Value 4503640056 | Price to Sales(TTM) 4.28 | ||
Enterprise Value to Revenue 4.69 | Enterprise Value to EBITDA 25.26 | Shares Outstanding 35775123 | Shares Floating 35453505 |
Shares Outstanding 35775123 | Shares Floating 35453505 | ||
Percent Insiders 0.98 | Percent Institutions 103.05 |
Upturn AI SWOT
Novanta Inc
Company Overview
History and Background
Novanta Inc. was founded in 2004, evolving from a division of General Scanning. It focuses on precision motion and vision solutions. Through strategic acquisitions and organic growth, it has expanded its portfolio to serve diverse industries.
Core Business Areas
- Photonics: Designs, manufactures, and sells precision photonics components and sub-systems. These products include lasers, laser beam steering components, and laser measurement devices.
- Vision: Develops and supplies embedded vision solutions including cameras, frame grabbers, and software, for applications in medical, industrial, and machine vision markets.
- Precision Motion: Provides precision motion control solutions, including motors, drives, encoders, and integrated motion systems. Applications are for medical, robotics, and industrial automation.
Leadership and Structure
The CEO is Matthijs Glastra. Novanta operates with a decentralized structure across its business segments, with a corporate headquarters providing strategic oversight.
Top Products and Market Share
Key Offerings
- Laser Beam Steering Components: Components and sub-systems to control direction and power. Market share is estimated at 15-20% with competitors like Scanlab and Cambridge Technology.
- Medical Grade Power Systems: Power solutions for medical equipment. Competitors include SL Power Electronics, and market share are not readily available.
- Machine Vision Camera: Machine vision cameras used in industrial inspection applications. Market share is relatively fragmented; Keyence, Cognex, and Teledyne are key competitors.
Market Dynamics
Industry Overview
The industries Novanta serves, including medical technology, industrial automation, and advanced industrial applications, are experiencing growth driven by technological advancements and increasing demand for precision and automation.
Positioning
Novanta is positioned as a technology innovator providing solutions to OEM customers. The firm focuses on high-growth markets with demands for high-performance.
Total Addressable Market (TAM)
The TAM for Novanta's served markets is estimated to be in the billions of dollars. Novanta is positioned to capture a larger share through product innovation and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Diversified end markets
- High-performance product portfolio
- Strong OEM relationships
- History of successful acquisitions
- Innovative technology
Weaknesses
- Dependence on key OEM relationships
- Exposure to cyclical industries
- Potential for product obsolescence
- Integration risk with acquisitions
Opportunities
- Expanding into new geographic markets
- Developing new applications for existing products
- Acquiring complementary technologies
- Capitalizing on trends in automation and medical technology
Threats
- Increased competition
- Economic downturns
- Technological disruptions
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- COHR
- IPGP
- IIVI
Competitive Landscape
Novanta competes based on its technological expertise, product quality, and OEM relationships. The firm holds a leading position in multiple market segments
Major Acquisitions
Laser Optek
- Year: 2020
- Acquisition Price (USD millions): 150
- Strategic Rationale: Expanded Novanta's offerings in medical laser technology.
Growth Trajectory and Initiatives
Historical Growth: Novanta has demonstrated consistent growth over the past several years, driven by organic growth and strategic acquisitions.
Future Projections: Analysts project continued revenue and earnings growth for Novanta, supported by favorable industry trends and the company's strong competitive position.
Recent Initiatives: Recent initiatives include expanding into new geographic markets and investing in R&D to develop new products and technologies.
Summary
Novanta is a strong company with solid financials and consistent growth, bolstered by strategic acquisitions and a diversified portfolio. Their positioning in high-growth markets offers strong opportunities for further expansion. Dependence on OEM relationships and economic cyclicality remain as key considerations.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change over time.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Novanta Inc
Exchange NASDAQ | Headquaters Bedford, MA, United States | ||
IPO Launch date 2016-01-04 | CEO & Chairman of the Board Mr. Matthijs Glastra | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 3000 | Website https://www.novanta.com |
Full time employees 3000 | Website https://www.novanta.com | ||
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.